CELLTRION Pharm has ranked among the top searched stocks for 13 days in the past month.


As of 2:31 PM on the 9th, CELLTRION Pharm is trading at 208,300 KRW, up 1.86% from the previous day. This represents a 70.6% increase compared to November 16. CELLTRION Pharm is known as a company specializing in pharmaceuticals and health supplements.

Today, foreign investors have tentatively been recorded as net buyers of 58,063 shares. Over the past five days, individual investors have net purchased 77,976 shares, while foreign and institutional investors have net sold 46,174 shares and 20,551 shares, respectively.


On December 3, CELLTRION Pharm made headlines in the market with the issue "Intraday record high... Expectations for COVID-19 treatment development."





[Table] Foreign and Institutional Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing